146 related articles for article (PubMed ID: 18408083)
21. Dramatic MRI improvement with refractory neurosarcoidosis treated with infliximab.
Toth C; Martin L; Morrish W; Coutts S; Parney I
Acta Neurol Scand; 2007 Oct; 116(4):259-62. PubMed ID: 17824906
[TBL] [Abstract][Full Text] [Related]
22. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
23. Optic neuritis in inflammatory bowel disease.
Sedwick LA; Klingele TG; Burde RM; Behrens MM
J Clin Neuroophthalmol; 1984 Mar; 4(1):3-6. PubMed ID: 6233306
[TBL] [Abstract][Full Text] [Related]
24. [Improvement in visual acuity in a patient with ischaemic optic neuropathy (Horton arteritis) undergoing therapy with infliximab: a case report].
Benucci M; Manfredi M; Puce F; Zuccarini S
Recenti Prog Med; 2007 Dec; 98(12):624-6. PubMed ID: 18369037
[TBL] [Abstract][Full Text] [Related]
25. Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients.
Josselin L; Mahr A; Cohen P; Pagnoux C; Guaydier-Souquières G; Hayem G; Job-Deslandre C; Liferman F; Pourrat J; Guillevin L
Ann Rheum Dis; 2008 Sep; 67(9):1343-6. PubMed ID: 18445626
[TBL] [Abstract][Full Text] [Related]
26. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.
Piton G; Larosa F; Minello A; Becker MC; Mantion G; Aubin F; Deconinck E; Hillon P; Di Martino V
Liver Transpl; 2009 Jul; 15(7):682-5. PubMed ID: 19562700
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of idiopathic orbital inflammation with infliximab: an alternative to conventional steroid-sparing agents.
Miquel T; Abad S; Badelon I; Vignal C; Warzocha U; Larroche C; Morax S; Dhote R
Ophthalmic Plast Reconstr Surg; 2008; 24(5):415-7. PubMed ID: 18806671
[TBL] [Abstract][Full Text] [Related]
28. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic orbital inflammation with extraorbital extension: case series and review.
Zborowska B; Ghabrial R; Selva D; McCluskey P
Eye (Lond); 2006 Jan; 20(1):107-13. PubMed ID: 15920571
[TBL] [Abstract][Full Text] [Related]
30. Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-alpha.
Evereklioglu C; Borlu M
Br J Ophthalmol; 2008 Aug; 92(8):1034, 1148-9. PubMed ID: 18653594
[No Abstract] [Full Text] [Related]
31. Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up.
Odorcic S; Keystone EC; Ma JJ
Cornea; 2009 Jan; 28(1):89-92. PubMed ID: 19092414
[TBL] [Abstract][Full Text] [Related]
32. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
[TBL] [Abstract][Full Text] [Related]
33. Postoperative Crohn's disease: prevention and treatment.
El-Hachem S; Regueiro M
Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):249-56. PubMed ID: 19485807
[TBL] [Abstract][Full Text] [Related]
34. Infliximab treatment for resistant Achilles tendonitis.
Al-Asfar SM; Attar M; Shacfeh H
Saudi Med J; 2009 Sep; 30(9):1228-30. PubMed ID: 19750273
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model.
Choi B; Hwang Y; Kwon HJ; Lee ES; Park KS; Bang D; Lee S; Sohn S
J Dermatol Sci; 2008 Nov; 52(2):87-97. PubMed ID: 18585901
[TBL] [Abstract][Full Text] [Related]
36. [Use of a new anti-inflammatory agent, metiazinic acid, in ophthalmology].
Thomas C; Mignot R; Galoisy C
Bull Soc Ophtalmol Fr; 1970; 70(9):921-4. PubMed ID: 5526291
[No Abstract] [Full Text] [Related]
37. Idiopathic orbital inflammatory syndrome without pain: a case report.
Slagle WS; Boothe KH; Musick AN; Eckermann DR; Slagle AM
Optometry; 2010 Mar; 81(3):146-52. PubMed ID: 20211444
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of infliximab in active SLE: a pilot study.
Uppal SS; Hayat SJ; Raghupathy R
Lupus; 2009 Jul; 18(8):690-7. PubMed ID: 19502264
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of fistulating pouchitis with tumour necrosis factor-alpha-inhibitor (infliximab)].
Semb S; Nordgaard-Lassen I
Ugeskr Laeger; 2008 Dec; 170(50):4134-5. PubMed ID: 19091194
[TBL] [Abstract][Full Text] [Related]
40. Receptor expression in orbital inflammatory syndromes and implications for targeted therapy.
Ho VH; Chevez-Barrios P; Jorgensen JL; Silkiss RZ; Esmaeli B
Tissue Antigens; 2007 Aug; 70(2):105-9. PubMed ID: 17610415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
